Cleared Traditional

K251934 - qXR-Detect

K251934 is an FDA 510(k) clearance for qXR-Detect, manufactured by Qure.Ai Technologies. The device is a Class 2 Radiology device with product code MYN cleared through the Traditional 510(k) pathway after a 206-day FDA review.

K251934 · Qure.Ai Technologies · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2026
Decision
206d
Days
Class 2
Risk

K251934 is an FDA 510(k) clearance for the qXR-Detect. Classified as Analyzer, Medical Image (product code MYN), Class II - Special Controls.

Submitted by Qure.Ai Technologies (Mumbai, IN). The FDA issued a Cleared decision on January 16, 2026 after a review of 206 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2070 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Qure.Ai Technologies devices

FDA 510(k) Submission Details - K251934

510(k) Number K251934 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 2025
Decision Date January 16, 2026
Days to Decision 206 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized Yes - Predetermined Change Control Plan authorized FDA has pre-authorized specific future modifications to this device, a pathway common in AI/SaMD devices.
Regulatory Context
Review time vs. panel average
99d slower than avg
Panel avg: 107d · This submission: 206d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. PCCP authorized - AI/SaMD pathway.

MYN Device Classification - Class 2, Special Controls

Product Code MYN Analyzer, Medical Image
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2070
Definition For Information On The Myn Device, Please See: Https://www.federalregister.gov/documents/2020/01/22/2020-00494/radiology-devices-reclassification-of-medical-image-analyzers
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MYN Analyzer, Medical Image

All 36
Devices cleared under the same product code (MYN) and FDA review panel - the closest regulatory comparables to K251934.
Velmeni for Dentists (V4D) Endo-Perio
K252953 · Velmeni, Inc. · May 2026
Diagnocat
K252934 · DGNCT, LLC · Jan 2026
DS Core Detect
K253009 · Dentsply Sirona, Inc. · Jan 2026
DTX Studio Assist
K252086 · Nobel Biocare C/O Medicim NV · Nov 2025
Second Opinion® Panoramic
K250525 · Pearl, Inc. · Nov 2025
SugarBug (1.x)
K250264 · Bench7, Inc. · Nov 2025